YONGHE MED.GR.DL-0000025 (L97) — Net Asset Quality Index
YONGHE MED.GR.DL-0000025 (L97) has a Net Asset Quality Index of 46.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.70 Billion minus total liabilities of €914.47 Million yields net assets of €787.37 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of YONGHE MED.GR.DL-0000025 for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
YONGHE MED.GR.DL-0000025 Net Asset Quality Index Over Time (2021–2025)
This chart shows how YONGHE MED.GR.DL-0000025's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 46.3%, representing net assets of €787.37 Million against total assets of €1.70 Billion EUR. For live market cap and overall valuation, see L97 market cap overview.
Annual Net Asset Quality Index for YONGHE MED.GR.DL-0000025 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for YONGHE MED.GR.DL-0000025 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See L97 net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 46.3% | €787.37 Million | €1.70 Billion | €914.47 Million | ▲ +4.9 pp |
| 2024 | 41.4% | €713.80 Million | €1.73 Billion | €1.01 Billion | ▲ +2.8 pp |
| 2023 | 38.5% | €942.25 Million | €2.44 Billion | €1.50 Billion | ▼ -15.6 pp |
| 2022 | 54.1% | €1.59 Billion | €2.93 Billion | €1.35 Billion | ▲ +1.0 pp |
| 2021 | 53.1% | €1.70 Billion | €3.20 Billion | €1.50 Billion | — |